Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial-Reference-Cited by-同舟云学术

Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: Treatment results and prognostic factor analysis in a multi-centre trial

Published:1994-01 Issue:1 Volume:5 Page:49-55
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Köppler H.,Pflüger K.-H.,Eschenbach I.,Pfab R.,Birkmann J.,Zeller W.,Holle R.,Steinhauer U.E.,Gropp C.,Oehl S.,Lennert K.,Parwaresch M.R.,Kuhn H.,Drings P.,Gossmann H.H.,Khoury M.,Schubotz R.,Havemann K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/5/1/49/609613/5-1-49.pdf

Reference34 articles.

1. Hydroxyldaunomycin (adriamycin) combination-chemotherapy in malignant lymphoma;McKelvey;Cancer,1976

2. CHOP is curative in thirty percent of patients with large cell lymphoma: A twelve year Southwest Oncology Group follow up;Coltman,1986

3. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six drug COB-BLAM regimen;Laurence;Ann Intern Med,1982

4. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high-dose methotrexate alternating with standard agents (M-BACOD);Skarin;J Clin Oncol,1983

5. The m-BACOD combination chemotherapy regimen in large cell lymphoma: Analysis of the completed trial and comparison with the M-BACOD regimen;Shipp;J Clin Oncol,1990

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma;Cancers;2021-12-09

2. Dose-intensified treatment of diffuse large B-cell lymphomas;European Journal of Cancer Supplements;2008-01

3. Aspects of Chemotherapy Schedules in Young and Elderly Patients with Aggressive Lymphoma;Clinical Lymphoma and Myeloma;2007-12

4. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Annals of Oncology;2007-01

5. Dose-Intensified Treatment of Advanced-Stage Diffuse Large B-Cell Lymphomas;Seminars in Hematology;2006-10